Navigation Links
Res-Q Gains Rights To Market Orosine - a Breakthrough, Patented, Natural Heart Supplement That Cardiologists Are Calling the 'Ultimate Cardio Protection' Against Heart Attacks, Strokes and Heart Failure.
Date:12/10/2008

PALM, Pa., Dec. 10 /PRNewswire/ -- N3 Oceanic, Inc. announced the addition of Orosine to its heart-healthy Res-Q line of products. Orosine was developed by cardiologist Dr. Jeffrey Shapiro, MD, Assistant Professor of Internal Medicine / Cardiology at Columbia Presbyterian Hospital and NYU Langone Medical Center, who has been giving the formula to his patients for the last two years with life-changing results. Dr. Shapiro states, Orosine is the most significant natural product I have ever used for both the treatment and prevention of heart disease. This is the first product of its kind that works directly on the cells, to improve the delivery of oxygen to the heart, relax blood vessels and improve blood flow to the heart, thus reducing the risk of a heart attack."

Damage to the cells can occur from years of being overweight, stress, high blood pressure, high cholesterol, atherosclerosis, high blood sugar and existing heart disease. Most people have one or more of these risk factors as they begin to age. Many people may even be walking around feeling no symptoms at all. Orosine is essential for people with risk factors as well as those who have already suffered a heart attack, because it can help prevent secondary complications and ultimately heart failure.

Res-Q Orosine is a patented all-natural formula made up of two main ingredients, inosine and orotate, both naturally fermented from plant matter. These ingredients have years of research and clinical trials documenting their safety and powerful benefits to the weakened heart.

AboutN3Oceanic,Inc.

N3 Oceanic, Inc. has been a leader in the nutraceuticals industry since its inception over 20 years ago. N3's premium supplement line, Res-Q products, offer the finest proprietary blend of all-natural ingredients with a focus on heart health and prevention. For more information, such as case studies on Dr. Shapiro's patients or to hear an audio clip of cardiologists Dr. Shapiro and Dr. Frederic Vagnini discuss Orosine, please go to www.myResQproducts.com.

Dr. Vagnini is a board-certified cardiothoracic surgeon who, after more than 20 years of performing heart surgery, has turned his clinical practice to prevention and nutrition. He is the medical director of two Heart, Diabetes and Longevity Centers in New York City and Long Island, where he sees patients on a daily basis.

Res-Q is a registered trademark of N3 Oceanic, Inc.


'/>"/>
SOURCE N3 Oceanic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
2. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
3. Despite overeating, morbidly obese mice gain protection against diabetes
4. Alvarado Hospital Files Countersuit Against Blue Shield
5. Texas Supreme Court Rules Against Medicare HMOs in Hospital Reimbursement Fight
6. Claim Filed Against the Company and Nine Other Defendants in the Haifa Magistrates Court
7. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
8. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
9. $52.5 Million Settlement Against Sepracor Inc. Approved
10. The fight against colorectal cancer
11. Especially Yours and Paula Young Team up with Diahann Carroll and Jaclyn Smith in the Fight Against Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Atlanta, Georgia (PRWEB) , ... January 19, 2017 ... ... Reconstructive Surgeons hosts the Atlanta Breast Surgery Symposium, a conference where hundreds of ... latest advancements in breast surgery. Covering topics from cosmetic breast augmentation ...
(Date:1/18/2017)... , ... January 18, 2017 , ... A recent video ... a global discussion about the benefits of fidgeting to relieve stress and anxiety. ... Daniel. Their Think Ink Pen had just completed a successful Kickstarter campaign raising ...
(Date:1/18/2017)... LAUDERDALE, FL (PRWEB) , ... January 18, 2017 ... ... how to manage it from the number one doctor-recommended OTC antiperspirant, Certain Dri. ... and often go untreated. , Certain Dri created this infographic to explain the ...
(Date:1/18/2017)... NJ (PRWEB) , ... January ... ... the specialty pharmacy industry’s leading journal and most-read publication among specialty pharmacists ... University Medical Center through its Strategic Alliance Partnership (SAP) program, announced Brian ...
(Date:1/18/2017)... ... 18, 2017 , ... PrideStaff, a national, franchised staffing ... Paula Turner Pizarro, was recently featured on Fox Business Network's Worldwide Business with ... business leaders from across the globe, provides viewers an opportunity to find solutions ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 18, 2017 The drug ... billion by 2021 from USD 1,179.20 billion in 2016, ... Increasing prevalence of chronic diseases, increasing demand for ... factors driving the growth of this market. Whereas, self-administration ... generic drugs offer significant growth opportunities for players operating ...
(Date:1/18/2017)... PUNE, India , January 18, 2017 /PRNewswire/ ... Research, titled, "Breast Imaging Technologies Market by Type: Global Opportunity ... imaging technologies market size was valued at $2,544 million in ... growing at a CAGR of 8.4% from 2016 to 2022. ... together accounted for over three-fourths market share in ...
(Date:1/18/2017)... Jan. 18, 2017   Regenicin, Inc. (OTC ... specializing in the development and commercialization of regenerative cell ... organs, recently reported the Company,s operating results for 2016 ... As the Company described in its recent 10-K ... of substantial accomplishments. The Company,s contract laboratory completed its ...
Breaking Medicine Technology: